India to Belarus: Albendazole Export Trade Route
India has recorded 221 verified shipments of Albendazole exported to Belarus, representing a combined trade value of $2.7M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $12.3K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 89% of total export value with 195 shipments worth $2.4M USD. On the buying side, INTERFARMAX is the largest importer in Belarus with $434.0K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Belarus Albendazole corridor is one of India's established pharmaceutical export routes, with 221 shipments documented worth a combined $2.7M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's albendazole manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $12.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with albendazole's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 55.6%, placing it at rank #6 among India's top albendazole export destinations globally.
On the import side, key buyers of Indian albendazole in Belarus include INTERFARMAX, DOMINANTAPHARM, VITPHARMA MARKET and 27 others. INTERFARMAX is the single largest importer with 26 shipments valued at $434.0K USD.
